Questions? 10 seconds to sign up
Join the platform
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
November 16, 2025
Approximately 5 minutes
UK Export Controls for Medicines: Special Regulatory Rules and Compliance Duties
UK Export Controls for Medicines: Special Regulatory Rules and Compliance Duties
1. Purpose and regulatory context
The United Kingdom applies special regulatory rules to the export of drugs and medicines to ensure that exported products meet legal, safety, and international control requirements. These rules apply whether medicines are exported for commercial supply, humanitarian use, or manufacture and processing abroad, and they operate alongside customs and trade controls.
Source: Export drugs and medicines: special rules
2. Medicines exported outside the UK market
Medicines that are manufactured or assembled in the UK solely for export do not require a UK marketing authorisation, provided they are not supplied on the UK market. However, such products must still be manufactured in accordance with UK good manufacturing practice (GMP) and meet the legal requirements of the importing country.
Source: Export drugs and medicines: special rules
3. Licensing and manufacturer responsibilities
Exporters must hold the appropriate manufacturer or wholesale dealer licences, depending on the nature of the activity. This includes ensuring that:
- Manufacturing and batch certification are performed by authorised entities
- Exported medicines are not falsely represented as UK-authorised products
- Records are maintained to demonstrate compliance with export conditions
Failure to hold the correct licence may result in enforcement action by the MHRA.
Source: Export drugs and medicines: special rules
4. Controlled drugs and additional authorisations
Medicines containing controlled drugs are subject to additional export controls. Exporters may need:
- Home Office export licences
- Import permits from the destination country
- Advance notifications or declarations
These requirements apply regardless of whether the product is licensed in the UK.
Source: Export drugs and medicines: special rules
5. Export documentation and labelling considerations
Exported medicines must be accompanied by accurate documentation, including batch certification and shipping records. Labelling and packaging may differ from UK market requirements, but must comply with:
- Legal and regulatory requirements of the importing country
- Any international conventions or bilateral agreements
Export-only labelling must not mislead recipients into assuming UK authorisation where none exists.
Source: Export drugs and medicines: special rules
6. Role of the MHRA and compliance oversight
The Medicines and Healthcare products Regulatory Agency (MHRA) oversees compliance with export rules through licensing, inspection, and enforcement powers. Exporters must be able to demonstrate, upon request, that all exported drugs and medicines comply with UK export regulations and applicable international obligations.
Source: Export drugs and medicines: special rules
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Understanding the Role of a Responsible Person (Import) in the UK
Guidance on the duties and requirements for acting as a Responsible Person (import) for certain products imported into Great Britain under UK medicines law.
Approximately 5 minutes
Importing Human Medicines into the UK: Licensing, Unlicensed Products, and Regulatory Costs
UK wholesalers and manufacturers must comply with specific regulatory requirements when importing human medicines, including unlicensed products, covering licensing routes, responsibilities, and applicable fees.